Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. Its structure enables selective modulation of protein kinases involved in cell proliferation, making it valuable in developing drugs for oncology. The compound’s fluorinated pyridopyrimidine core enhances binding affinity to specific enzyme targets, while the tert-butyl carbamate group aids in solubility and stability during synthesis. It is primarily employed in late-stage functionalization to build more complex bioactive molecules.